Metadata
- Name
- A Study to Evaluate Rucaparib in Patients With Solid Tumors and With Deleterious Mutations in HRR Genes
- Repository
- ClinicalTrials.gov
- Identifier
- clinicaltrials:NCT04171700
- Description
- A Phase 2, open-label, single-arm trial to evaluate the response of rucaparib in patients
with various solid tumors and with deleterious mutations in Homologous Recombination Repair
(HRR) genes. - Data or Study Types
- clinical trial
- Keywords
- colorectal cancer, HRD, germline, fallopian tube cancer, prostate cancer, leiomyosarcoma, esophageal cancer, FANCA, primary peritoneal cancer, basket trial, platinum sensitive, gastric cancer, PARPi, locally advanced, endometrial cancer, bladder cancer, rucaparib, ovarian cancer, metastatic, RAD51C, platinum resistant, tumor agnostic, PALB2, BRCA1, sarcoma, somatic, lung cancer, CO-338, DNA repair, homologous recombination, pancreatic cancer, LODESTAR, HRR, RAD51D, cervical cancer, RAD51B, solid tumor, rare tumor, PARP inhibitor, BRIP1, colon cancer, ampullary carcinoma, BARD1, breast cancer, BRCA2, basket study, carcinosarcoma, RAD51
- Source Organization
- Unknown
- Access Conditions
- available
- Year
- 2019
- Access Hyperlink
- https://clinicaltrials.gov/ct2/show/NCT04171700
Distributions
- Encoding Format: HTML ; URL: https://clinicaltrials.gov/ct2/show/results/NCT04171700